Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Act Capital Management, Llc
Form 13F · Q2 2026

Act Capital Management, Llc

CIK 1442273Filed 2026-07-2913F-HR View the filing on EDGAR ↗
$153M
Reported book value
62
Positions
3
Quarters on record
Top 50
Positions

Act Capital Management, Llc — holdings

Top 50 positions of 62, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1KRYS Krystal Biotech Inc45,000−25.6%$17M10.9%
2TGTX Tg Therapeutics Inc251,025+0.8%$14M9.0%
3ABIVAX SA Abivax Sa97,000+36.8%$13M8.4%
4CVX Chevron Corporation75,000+0.0%$12M8.1%
5EXXON MOBIL CORP Exxon Mobil Corp78,500+12.1%$11M7.0%
6ARWR Arrowhead Pharmaceuticals In110,100+33.5%$9M5.9%
7VKTX Viking Therapeutics Inc209,300+0.0%$8M5.3%
8CELC Celcuity Inc62,150−32.2%$7M4.2%
9NKTR Nektar Therapeutics89,300+26.0%$6M4.1%
10TSLA Tesla Inc10,800—$5M3.0%
11CYTK Cytokinetics Inc47,500−26.4%$4M2.6%
12ASTS Ast Spacemobile Inc43,500—$4M2.5%
13PVLA Palvella Therapeutics Inc Ne22,500—$3M2.2%
14AMZN Amazon Com Inc12,900−60.9%$3M2.0%
15NUVB Nuvation Bio Inc520,000+79.3%$3M1.9%
16XENE Xenon Pharmaceuticals Inc48,000+43.3%$3M1.9%
17ET Energy Transfer L P133,100+0.0%$3M1.7%
18BE Bloom Energy Corp7,500+66.7%$2M1.5%
19FCX Freeport Mcmoran Inc32,500−15.6%$2M1.3%
20NBIS Nebius Group N.V.6,800—$2M1.2%
21ALMS Alumis Inc51,600−70.4%$1M0.9%
22AMBA Ambarella Inc16,000—$1M0.9%
23CBRS Cerebras Systems Inc5,600—$1M0.8%
24DFTX Definium Therapeutics Inc25,000—$1M0.8%
25NOK Nokia Corp82,000—$1M0.7%
26KURA Kura Oncology Inc88,900+20.3%$975,2330.6%
27PRAX Praxis Precision Medicines I2,700+0.0%$903,9330.6%
28AAOI Applied Optoelectronics Inc6,000−76.8%$888,9600.6%
29CCJ Cameco Corp8,400—$855,6240.6%
30GLUE Monte Rosa Therapeutics Inc35,000+55.6%$847,0000.6%
31RGNX Regenxbio Inc67,500+20.5%$808,6500.5%
32MLYS Mineralys Therapeutics Inc28,100—$758,1380.5%
33GBTC Grayscale Bitcoin Trust Etf15,400+0.0%$701,0080.5%
34VIR Vir Biotechnology Inc64,300+0.0%$655,2170.4%
35PALI Palisade Bio Inc307,500+19.4%$642,6750.4%
36PLTR Palantir Technologies Inc5,500—$641,6850.4%
37ON On Semiconductor Corp6,000—$567,2400.4%
38HCC Warrior Met Coal Inc6,000+0.0%$486,9600.3%
39CRGY Crescent Energy Company45,000+0.0%$441,9000.3%
40MBX Mbx Biosciences Inc8,000−11.1%$441,6000.3%
41KEEL Keel Infrastructure Corp74,500—$427,6300.3%
42CMPS Compass Pathways Plc30,000+93.5%$424,5000.3%
43CRVS Corvus Pharmaceuticals Inc27,000—$403,3800.3%
44ACOG Alpha Cognition Inc51,500+0.0%$371,8300.2%
45KYTX Kyverna Therapeutics Inc40,000+33.3%$356,4000.2%
46AXTI Axt Inc4,900—$353,1920.2%
47INFQ Infleqtion Inc25,000—$333,0000.2%
48SRRK Scholar Rock Hldg Corp6,000−44.4%$330,0000.2%
49PATH Uipath Inc30,000−40.0%$326,1000.2%
50ANL Adlai Nortye Ltd27,000—$310,5000.2%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.